Since the beginning of its operations in January 2016, NOVULIS has treated more than 6000 patients, being recognized as one of the ten social enterprises with the greatest impact and the largest number of beneficiaries in Latin America.

After a demanding selection process, involving hundreds of Latin American social enterprises, Novulis has been chosen by I³ LATAM (Promoting Impact Innovation in Latin America) as one of the 10 ventures with the most innovative business models to solve social problems in the region.
I³ LATAM is a joint initiative of New Ventures, Ashoka, Hystra and COSUDE, launched in 2013 that seeks the best social entrepreneurs in Latin America, advises them and links them with potential investors.
During its first three years, I³ LATAM empowered 30 companies from 12 Latin American countries, helping them reach 10.8 million beneficiaries, generating almost 100 million dollars of savings.
Among the key points to be part of the I³ LATAM Generation are: to benefit a large number of low-income people, to have an innovative business model that solves a social problem, to have an entrepreneurial team really committed to social impact and high management capacity, among others.

Since the beginning of its operations in January 2016, NOVULIS has treated more than 6000 patients, being recognized as one of the ten social enterprises with the greatest impact and the largest number of beneficiaries in Latin America.
For Novulis, being an I³ LATAM company is an invaluable opportunity to scale our operations and continue to reach more and more patients who deserve access to quality dental health.

Greg Krupa, CEO of Novulis, presenting the company in the 8th edition of the FLII (Latin American Impact Investment Forum) in the city of Merida, Mexico.